Devyser Diagnostics AB (FRA:OL0) Total Assets: €43.64 Mil (As of Mar. 2026)


FRA:OL0 Devyser Diagnostics AB FRA:OL0
76 GF Score
Price €5.44
GF Value €14.09
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Devyser Diagnostics AB Total Assets?

Devyser Diagnostics AB FRA:OL0 -27.47% 76 Total Assets is €43.64 Mil as of Mar. 2026. GuruFocus rates FRA:OL0 with a GF Score™ of 76/100 and a GF Value™ of €14.09 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Devyser Diagnostics AB's Total Assets for the quarter that ended in Mar. 2026 was €43.64 Mil.

Warning Sign:

If a company builds assets at 48.2% a year, faster than its revenue growth rate of 21.5% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Devyser Diagnostics AB's average Total Assets Growth Rate was 16.10% per year. During the past 3 years, the average Total Assets Growth Rate was 42.00% per year. During the past 5 years, the average Total Assets Growth Rate was 48.20% per year.

During the past 9 years, Devyser Diagnostics AB's highest 3-Year average Total Assets Growth Rate was 60.80%. The lowest was 18.10%. And the median was 35.65%.

Total Assets is connected with ROA %. Devyser Diagnostics AB's annualized ROA % for the quarter that ended in Mar. 2026 was 2.48%. Total Assets is also linked to Revenue through Asset Turnover. Devyser Diagnostics AB's Asset Turnover for the quarter that ended in Mar. 2026 was 0.13.

Devyser Diagnostics AB  (FRA:OL0) Total Assets Explanation

Total Assets is connected with ROA %.

Devyser Diagnostics AB's annualized ROA % for the quarter that ended in Mar. 2026 is

ROA %=Net Income (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=1.076/( (43.162+43.644)/ 2 )
=1.076/43.403
=2.48 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Devyser Diagnostics AB's Asset Turnover for the quarter that ended in Mar. 2026 is

Asset Turnover
=Revenue (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=5.737/( (43.162+43.644)/ 2 )
=5.737/43.403
=0.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Devyser Diagnostics AB Total Assets Related Terms

Devyser Diagnostics AB Total Assets Historical Data

* Premium members only.

The historical data trend for Devyser Diagnostics AB's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Devyser Diagnostics AB Total Assets Chart

Devyser Diagnostics AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Assets
Get a 7-Day Free Trial Premium Member Only 44.48 45.54 45.60 41.19 43.16

Devyser Diagnostics AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41.46 41.87 41.81 43.16 43.64
FRA:OL0
76GF Score
Devyser Diagnostics AB FRA:OL0
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Devyser Diagnostics AB Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Devyser Diagnostics AB's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=32.557+10.604
=43.16

Devyser Diagnostics AB's Total Assets for the quarter that ended in Mar. 2026 is calculated as

Total Assets=Total Equity (Q: Mar. 2026 )+Total Liabilities (Q: Mar. 2026 )
=33.227+10.417
=43.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of €43.64 Mil mean?
Devyser Diagnostics AB (FRA:OL0) has a Total Assets of €43.64 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on Devyser Diagnostics AB and its competitors.
Is Devyser Diagnostics AB's Total Assets too high?
Devyser Diagnostics AB's current Total Assets is €43.64 Mil. Overall, Devyser Diagnostics AB has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Devyser Diagnostics AB's Total Assets compare to ABT and SYK?
Devyser Diagnostics AB's Total Assets of €43.64 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Medical Devices & Instruments company?
A good Total Assets depends on the Medical Devices & Instruments industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Devyser Diagnostics AB and its competitors. Devyser Diagnostics AB's current Total Assets is €43.64 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Devyser Diagnostics AB stock overvalued right now?
Based on GuruFocus' analysis, Devyser Diagnostics AB (FRA:OL0) is currently considered Significantly Undervalued. The stock's GF Value™ is €14.09, compared to a current price of €5.44 — trading 61.4% below its estimated fair value. The current Total Assets is €43.64 Mil. Devyser Diagnostics AB's overall GF Score™ is 76/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Devyser Diagnostics AB (FRA:OL0), the current Total Assets is €43.64 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Devyser Diagnostics AB (FRA:OL0) Overvalued in 2026?

Based on GuruFocus' analysis, Devyser Diagnostics AB stock appears to be undervalued. The current stock price of €5.44 is trading 61.4% below its estimated GF Value™ of €14.09. GuruFocus considers Devyser Diagnostics AB to be Significantly Undervalued.

Key valuation signals for FRA:OL0:

  • Total Assets: €43.64 Mil
  • GF Value™: €14.09 vs. price of €5.44 (61.4% below fair value)
  • GF Score™: 76/100 with 2 warning signs

No single metric tells the full story. See the FRA:OL0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Devyser Diagnostics AB Business Description

Other Exchanges DVYSR:Sweden
Address Branningevagen 12, Arsta, SWE, 120 54
Devyser Diagnostics AB is engaged in the development, manufacture, and sale of kits for genetic testing in routine diagnostic laboratories. The products are used for advanced genetic testing in the hereditary disease, oncology, and transplant fields, to enable targeted cancer treatment, the diagnosis of a large number of genetic diseases, and transplant patient follow-up.
76GF Score

Get the complete analysis for FRA:OL0

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.44
Price
€14.09
GF Value